Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Olmesartan | N-Alkylated Olmesartan | VL184009 | View |
Olmesartan | Olmesartan Anhydro Acid N1-Trityl Ethyl Ester | VE009133 | View |
Olmesartan | Olmesartan Dichloro Dimethyl trans-Isomer | VE006827 | View CAS 116857-05-7 |
Olmesartan | Olmesartan Dimer Ester | VL184007 | View CAS 1040250-19-8 |
Olmesartan | Olmesartan Dimer Impurity | VE0011115 | View CAS 1454571-97-1 |
Olmesartan | Olmesartan EP Impurity A | VL184002 | View CAS 144689-24-7 |
Olmesartan | Olmesartan EP Impurity B | VL184001 | View CAS 849206-43-5 |
Olmesartan | Olmesartan EP Impurity C | VL184006 | View CAS 879562-26-2 |
Olmesartan | Olmesartan EP Impurity D | VL184005 | View CAS 1020157-01-0 |
Olmesartan | Olmesartan Ethyl Ester | VL184003 | View CAS 144689-23-6 |
Olmesartan | Olmesartan Ethyl Methyl Analog | VL184013 | View CAS 1378863-74-1 |
Olmesartan | Olmesartan Impurity 1 | VL184015 | View CAS 1392475-91-0 |
Olmesartan | Olmesartan Impurity 12 | VE006624 | View CAS 124750-51-2 |
Olmesartan | Olmesartan Impurity 13 | VE007058 | View CAS 172875-53-5 |
Olmesartan | Olmesartan Impurity 2 | VL184010 | View CAS 358685-13-9 |
Olmesartan | Olmesartan Impurity 6 | VE0011428 | View CAS 144690-07-3 |
Olmesartan | Olmesartan Medoxomil Dimer Impurity | VL184011 | View |
Olmesartan | Olmesartan Medoxomil Impurity | VE009848 | View CAS 80841-78-7 |
Olmesartan | Olmesartan Medoxomil Impurity 4 | VE006921 | View CAS 95579-71-8 |
Olmesartan | Olmesartan Trityl Alcohol | VL184004 | View CAS 76-84-6 |
Olmesartan | Trityl Olmesartan | VL184016 | View CAS 144690-92-6 |
Olmesartan | 4, 5-Bis(chloromethyl)-1, 3-dioxol-2-one | VE008908 | View CAS 1443544-27-1 |
Olmesartan | (4R, 5S)-4, 5-Dichloro-4, 5-dimethyl-1, 3-dioxolan-2-one | VE0011425 | View CAS 116857-04-6 |
Olmesartan Related Compound
Olmesartan is a blood pressure medication (hypertension). Lowering blood pressure aids in the prevention of strokes, heart attacks, and renal disorders.
References
- NHS Choices. Olmesartan. 2023, www.nhs.uk/medicines/olmesartan/.
- “Use of the Combination of Olmesartan and Hydrochlorothiazide in EssentialHypertensionFull Text View – ClinicalTrials.gov.” Clinicaltrials.gov,2019,clinicaltrials.gov/ct2/show/NCT004305
FAQ’s
Is Olmesartan an ACE inhibitor or a beta blocker?
Olmesartan may have an ACE inhibitory activity in addition to an Ang II receptor blocking action, preventing a rise in Ang II levels and protecting cardiovascular remodelling by increasing cardiac nitric oxide generation and endogenous Ang-(1-7) via ACE2 overexpression.
What combination is presented with Olmesartan?
Olmesartan medoxomil combined with hydrochlorothiazide
Why medoxomil combined with hydrochlorothiazide?
In moderate-to-severe hypertension, it improves 24-hour blood pressure management.